Amneal Pharmaceuticals Stock Forecast
NASDAQ: AMRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 19.66 +0.05%
AMRX analyst consensus
Consensus (7 analysts)
strong_buy
Avg. price target
$22.71+15.57%
- Strong buy 3
- Buy 4
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 7 Wall Street analysts covering Amneal Pharmaceuticals (2026-10-07), 7 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $22.71, with a high estimate of $27.00 and a low estimate of $20.00. The average target implies upside of 15.6% from the current price of $19.65.
The spread between the highest and lowest targets is 35.0%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for AMRX.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 3 | 43% |
| Buy | 4 | 57% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $20.00 | +1.78% |
| Average target | $22.71 | +15.57% |
| High target | $27.00 | +37.40% |